A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-licensed Ocrevus and EU-approved Ocrevus
Clinical trial NCT07606521 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07606521
- Sponsor
- Polpharma Biologics International AG
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2027-12-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.